You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • THU0397 Increased Bone Mass and Bone Strength by Sclerostin Antibody (Scl-Ab) is Maintained by a RANKL Inhibitor in OVX Rats with Established Osteopenia

Citation Tools

Article menu
Download PDFPDF
Poster Presentation
Spondyloarthritis - treatment
THU0397 Increased Bone Mass and Bone Strength by Sclerostin Antibody (Scl-Ab) is Maintained by a RANKL Inhibitor in OVX Rats with Established Osteopenia

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ominsky M, Li X, Warmington K, et al
THU0397 Increased Bone Mass and Bone Strength by Sclerostin Antibody (Scl-Ab) is Maintained by a RANKL Inhibitor in OVX Rats with Established Osteopenia
Annals of the Rheumatic Diseases 2013;72:A299-A300.